This company has been acquired
Entasis Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Key information
90.2%
Debt to equity ratio
US$15.01m
Debt
| Interest coverage ratio | n/a |
| Cash | US$33.55m |
| Equity | US$16.65m |
| Total liabilities | US$27.44m |
| Total assets | US$44.09m |
Recent financial health updates
Will Entasis Therapeutics Holdings (NASDAQ:ETTX) Spend Its Cash Wisely?
Dec 16
Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?
Aug 19Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?
Dec 01
Recent updates
Will Entasis Therapeutics Holdings (NASDAQ:ETTX) Spend Its Cash Wisely?
Dec 16Entasis Therapeutics: AstraZeneca Spin-Out Developing Targeted Antibacterial Products
Nov 17Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?
Aug 19Entasis Therapeutics shares rise after lining up ETX0462 poster presentation
Jun 18What Kind Of Shareholders Own Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)?
Feb 17Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?
Dec 01Financial Position Analysis
Short Term Liabilities: ETTX's short term assets ($39.9M) exceed its short term liabilities ($24.1M).
Long Term Liabilities: ETTX's short term assets ($39.9M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: ETTX has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ETTX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ETTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ETTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 10.6% each year